comparemela.com

Latest Breaking News On - Zhenping zhu - Page 1 : comparemela.com

HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital

/PRNewswire/ HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, today.

Jing louUnited statesSteven dasong wangZhenping zhuResearch at imclone systemsSunshine guojian pharmaceutical shanghai co ltdSbio groupKadmon holdingsBio therapeuticsHankang capitalYonghua investmentSunshine guojian pharmaceuticalChief executive officerChief scientific officerExecutive vice presidentVice president

HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital

/PRNewswire/ HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, today.

Jing louUnited statesSteven dasong wangZhenping zhuResearch at imclone systemsSunshine guojian pharmaceutical shanghai co ltdSbio groupKadmon holdingsBio therapeuticsHankang capitalYonghua investmentSunshine guojian pharmaceuticalChief executive officerChief scientific officerExecutive vice presidentVice president

HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Jing louUnited statesSteven dasong wangZhenping zhuResearch at imclone systemsSunshine guojian pharmaceutical shanghai co ltdSbio groupKadmon holdingsBio therapeuticsHankang capitalYonghua investmentSunshine guojian pharmaceuticalChief executive officerChief scientific officerExecutive vice presidentVice president

vimarsana © 2020. All Rights Reserved.